465 related articles for article (PubMed ID: 25208922)
1. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
2. Abnormal metabolic networks in atypical parkinsonism.
Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D
Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116
[TBL] [Abstract][Full Text] [Related]
3. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
4. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Fabbrini G; Fabbrini A; Suppa A
Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
[TBL] [Abstract][Full Text] [Related]
5. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
6. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
[TBL] [Abstract][Full Text] [Related]
8. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an optimized [
Caminiti SP; Alongi P; Majno L; Volontè MA; Cerami C; Gianolli L; Comi G; Perani D
Eur J Neurol; 2017 May; 24(5):687-e26. PubMed ID: 28244178
[TBL] [Abstract][Full Text] [Related]
10. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
11. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
13. PET Molecular Imaging in Atypical Parkinsonism.
Xu Z; Arbizu J; Pavese N
Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
15. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
16. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
Lass P; Sławek J; Derejko M; Dubaniewicz M
Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
Zhao P; Zhang B; Gao S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
[TBL] [Abstract][Full Text] [Related]
18. Voxel-based distribution of metabolic impairment in corticobasal degeneration.
Garraux G; Salmon E; Peigneux P; Kreisler A; Degueldre C; Lemaire C; Destée A; Franck G
Mov Disord; 2000 Sep; 15(5):894-904. PubMed ID: 11009197
[TBL] [Abstract][Full Text] [Related]
19. SPECT Molecular Imaging in Atypical Parkinsonism.
Brumberg J; Isaias IU
Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
[TBL] [Abstract][Full Text] [Related]
20. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
